Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
Recruiting · NCT07260175 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Recruiting | Phase 2 | 2026-08-12 | NCT07260175 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 34 |
| Servier Affaires Médicales | 8 |
| Servier Deutschland GmbH | 3 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asklepios Tumorzentrum Hamburg | Hamburg | Germany | 2 |
| Klinikum Oldenburg AöR | Oldenburg | Germany | 4 |
| Klinikum rechts der Isar TU München | München | Germany | 2 |
| Krankenhaus Barmherzige Brüder Regensburg | Regensburg | Germany | 4 |
| Krankenhaus Nordwest | Frankfurt | Germany | 7 |
| LMU Klinikum Großhadern | München | Germany | 1 |
| Uniklinik RWTH Aachen | Aachen | Germany | 11 |
| Uniklinikum Essen | Essen | Germany | 1 |
| Uniklinikum Jena | Jena | Germany | 1 |
| Universitätsklinik Gießen und Marburg GmbH Standort Gießen | Giessen | Germany | 1 |
| Universitätsklinikum Bonn | Bonn | Germany | 29 |
| Universitätsklinikum Frankfurt | Frankfurt | Germany | 29 |
| Universitätsklinikum Mannheim | Mannheim | Germany | 21 |
| Universitätsmedizin Göttingen | Göttingen | Germany | 1 |
| Universitätsmedizin Mainz | Mainz | Germany | 11 |